Santa Cruz Biotechnology provides a broad selection of IRG-47 monoclonal antibodies for research focused on understanding IRG-47 protein functions. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IRG-47, or Interferon-Inducible GTPase 47, plays a critical role in the immune response, particularly in the defense against intracellular pathogens. IRG-47 is involved in the regulation of autophagy and the modulation of inflammatory responses, making it an important target for studies related to infectious diseases and immune system disorders. Understanding IRG-47 function can provide insights into therapeutic strategies for various diseases. Researchers worldwide utilize IRG-47 monoclonal antibodies to advance their studies in immune regulation and pathogen defense mechanisms. The extensive applications of IRG-47 monoclonal antibodies enable detailed investigation of cellular pathways and immune responses. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to immunology and infectious disease research.